

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S116–S348
S345
Portuguese versions of the: FMPS, Hewitt and Flett MPS/H&FMPS,
Life Orientation Test Revised/LOT-R, State-Trait Anxiety Inven-
tory/STAI, and Profile of Mood States/POMS.
Results
Correlations between each itemand corrected FMPS total
scores/corrected total subscales scoreswere
≥
0.20 for the items 13,
15, 25, 31, 35 and 10, 2, 25, and 26, respectively. The internal con-
sistency of FMPS was high ( : .857) with 32 items contributing for
this consistency (exceptions: 13, 25 and 31). The principal com-
ponent analysis of the 35 items with factors varimax rotation was
performed. The three items with higher loading in each factor that
also contributed to the FMPS reliability were selected for the FMPS
shortened version (FMPS-18). The principal component analysis of
the 18 items with factors varimax rotation showed that six factors
explained 74.6% of FMPS-18 total variance. These factors revealed
adequate internal consistency ( : O = 0.740; PC = 0.859; PE = 0.847;
PS = 0.726; CM= 0.740; DA = 0.832; total = 0.768). Convergent cor-
relations between FMPS and the matched FMPS-18 scores were
0.839 to 0.971 (all
P
< .01). Correlations of the FMPS-18 and FMPS
with H&F-MPS, STAI, LOT-R and NA/PA scores were of similar sig-
nificance and valence.
Conclusion
FMPS-18 is a brief, reliable and valid instrument to
measure perfectionism.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2016.01.770EW653
The H&F-Multidimensional
Perfectionism Scale 13 (H&F-MSP13):
Construct and convergent validity
M.J. Soares
∗
, A.T. Pereira , A. Araújo , D. Silva , J. Valente ,
V. Nogueira , C. Roque , A. Macedo
Faculty of Medicine, University of Coimbra, Department of
Psychological Medicine, Coimbra, Portugal
∗
Corresponding author.
Introduction
The Hewitt and Flett Multidimensional Perfection-
ism Scale (H&F-MPS) is one of the most used measures of
perfectionism. Their 45-items evaluate self-Oriented (SOP), Self-
Prescribed (SPP), and Other Oriented (OOP) perfectionism.
Objectives
To study the internal consistency and convergent
validity of the H&F-MSP13.
Methods
One hundred and ninety-two university students
(78.1% females), aged 19.74 years (sd = 2.10; range: 17–28) com-
pleted the Portuguese versions of H&F-MPS (Soares et al., 2003)
and of Frost et al. MPS (F-MPS) (Amaral et al., 2013). Thirteen items
were selected from the Portuguese version of the H&F-MPS, based
on their loading in the factor (0.60 and over) (Soares et al., 2003).
Results
The H&FMPS13 revealed good internal consistency
( = 0.816). The corrected item-total subscale Spearman’s correla-
tions were high (from 0.418 to 0.820). The principal component
analysis with factors varimax rotation produced three fac-
tors, which revealed acceptable/good internal consistency (SOP:
explained variance/EV = 35.4%, = .900; SPP: EV = 16.3%, = 0.695;
OOP: EV = 10.8%,
= 0.709). The correlations between the H&F-
MSP13 scores and the matching scores of the H&F-MPS were
high (from
r
= 0.745 to
r
= 0.945, all
P
< .01), suggesting that both
scales measure similarly the constructs. The H&F-MSP13 and
the H&F-MPS total scores demonstrate good convergent validity
with the total score of F-MPS, as indicated by the correla-
tions (
r
= 0.581/
r
= 0.636, respectively). The correlations similarities
between the H&F-MSP13 and H&F-MSP dimensions and the F-MPS
dimensions and total scores were also considerable.
Conclusions
The H&F-MSP13 is a valid instrument to measure
perfectionism that reveals convergent validity with the F-MPS,
retaining the adequate psychometric properties of the H&F-MPS
and its administration is less time consuming.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2016.01.771EW654
Impact of psychotic symptoms in
functionality and quality of life of
major depression patients in
maintenance/continuation
eletroconvulsive therapy (M/C ECT)
A. Tarelho
1 ,∗
, A. De Arriba Arnau
2, M. Robles Martínez
3,
M. Sarachaga Urretavizcaya
2, V. Soria Tomás
2,
J.M. Menchón Magri˜ná
2, N. Salvat Pujol
21
Centro Hospitalar de Leiria, EPE, Psychiatry service, Leiria, Portugal
2
Bellvitge University Hospital, Psychiatry Department, Barcelona,
Spain
3
Hospital Universitario Puerta del Mar, Psychiatry, Cádiz, Spain
∗
Corresponding author.
Introduction
Psychotic depression has a higher rate of disability
and relapse than non psychotic depression, however the optimal
maintenance treatment after an acute response to either the antide-
pressant/antipsychotic combination or an ECT course is unclear
(Rothschild, 2013). Although ECT is an effective therapy in affective
disorders andM/C ECT is used to achieve andmaintain patient’s sta-
bility (Brown, 2014), very little is known about its implications in
functionality or quality of life.
Objectives
To study the relation between psychotic symptoms
and functionality and quality of life in patients with Major Depres-
sive Disorder (MDD) undergoing M/C ECT.
Methodology
Transversal descriptive study of a sample of 17
MDD patients in M/C ECT. Administration of SF-36 (quality of life
related to health), FAQ (functionality), Family APGAR, MMSE, GAF,
HDRS. Informed consent. Statistical analysis with SPSS18.
Results
The mean age of the sample was 72.47 years, 58.8%
presented with psychotic symptoms and 41.2% with melancholic
symptoms. We only found a statistically significant negative corre-
lation between the Family APGAR and the presence of psychotic
symptoms (
U
= –2.291,
P
= 0.025), without other differences in
terms of functionality or quality of life.
Conclusions
This study supports that there is no implication in
the presence of psychotic symptoms regarding functionality or
quality of life among the patients undergoing M/C ECT. We empha-
size the need for randomized control trials to disentangle the effects
of multiple variables on the functionality and quality of life of
patients in M/C ECT.
Disclosure of interest
The authors have not supplied their decla-
ration of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2016.01.772EW655
A novel, disease-specific clinical global
impression scale (CGI) in Down
syndrome
B. Rothman
ProPhase LLC, Science, New York City, USA
Background
The CGI receives criticism due to its ambiguous sco-
ring criteria, unstable reliability, and because CGI ratings may be
too general to provide meaningful information about patient status
or treatment response. This is problematic in studies of neurode-
velopmental disorders such as Down syndrome (DS) that violate
key assumptions underlying the CGI (i.e., that the disease is poten-
tially reversible) and are highly variable in observed impairments.
In DS, the CGI requires a higher level of standardization. This study
examined the psychometric properties of a novel standardized CGI